Anna Klimczak

Statistics

Publications

Citations

437

H-Index

Active since

2012

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

Holy Cross University

Jagiellonian University

Gdańsk Medical University

Medical University of Lodz

Anna Klimczak is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in oncology, medicine, and malignant neoplasms.

ORCID

Publications per year

2012–2023

Publications

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

Piotr Rutkowski, Elżbieta Bylina, Anna Klimczak et al. · BMC Cancer · 2012 · 95 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate – The impact of fibrosarcomatous transformation

Piotr Rutkowski, Anna Klimczak, Iwona Ługowska et al. · European Journal of Surgical Oncology · 2017 · 85 citations · Full text

Medicine, Dermatology, Oncology +10

Long-term Results of Therapy with Sunitinib in Metastatic Alveolar Soft Part Sarcoma

Paulina Jagodzińska-Mucha, Tomasz Świtaj, Katarzyna Kozak et al. · Tumori Journal · 2017 · 41 citations

Medicine, Oncology, Pharmacology +17

Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer

Anna Klimczak, Radzisław Kordek, Jan Bitner et al. · Oncology Letters · 2016 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective

Tomasz Świtaj, Aleksandra Sobiborowicz, Paweł Teterycz et al. · Journal of Clinical Medicine · 2021 · 25 citations · Full text

Medicine, Oncology, Pathology +9

1–5 of 15